FORTAMET
METFORMIN HYDROCHLORIDE
Approval overview FORTAMET is listed in Drugs@FDA under application 021574 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ANDRX LABS LLC Submission history Latest submission status date: 2018-11-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview FORTAMET is listed in Drugs@FDA under application 021574 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ANDRX LABS LLC Submission history Latest submission status date: 2018-11-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.